Introduction
(1) Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan, USA (2) Jenkins/Pokempner Director of Complementary & Alternative Medicine, University of Michigan Medical Center (Dept of Urology), Ann…
(1) Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan, USA (2) Jenkins/Pokempner Director of Complementary & Alternative Medicine, University of Michigan Medical Center (Dept of Urology), Ann…
(1) Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan, USA (2) Jenkins/Pokempner Director of Complementary & Alternative Medicine, University of Michigan Medical Center (Dept of Urology), Ann…
(1) Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan, USA (2) Jenkins/Pokempner Director of Complementary & Alternative Medicine, University of Michigan Medical Center (Dept of Urology), Ann…
(1) Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan, USA (2) Jenkins/Pokempner Director of Complementary & Alternative Medicine, University of Michigan Medical Center (Dept of Urology), Ann…
(1) Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan, USA (2) Jenkins/Pokempner Director of Complementary & Alternative Medicine, University of Michigan Medical Center (Dept of Urology), Ann…
(1) Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan, USA (2) Jenkins/Pokempner Director of Complementary & Alternative Medicine, University of Michigan Medical Center (Dept of Urology), Ann…
(1) Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan, USA (2) Jenkins/Pokempner Director of Complementary & Alternative Medicine, University of Michigan Medical Center (Dept of Urology), Ann…
and Steven D. Shapiro2 (1) Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA (2) Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA Abstract…
Fig. 6.1 Pathways controlling eicosanoid production. Arachidonic acid is incorporated into membrane glycerophospholipids. Activation of cPLA2 hydrolyzes these lipids to produce free AA. Alternatively, AA can be derived from 2-arachidonylglycrol…
Model Tumor stage Initiation Promotion Progression/metastasis Adenocarcinoma Pro-inflammatory mediators Transcription factors NFκB, NRF2 NFκB NFκΒ, EGR-1 Cytokines/chemokines TNF, IL4Rα, IL17 IL6, IL17 MCP-1, MIF Eicosanoid pathway cPLA2 EP2 (PGE2) Nuclear…